Free Trial
→ Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway (From Interactive Offers) (Ad) Free MAZE Stock Alerts

Maze Therapeutics (MAZE) Institutional Ownership

Maze Therapeutics logo
$16.31 +0.30 (+1.87%)
As of 11:03 AM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Maze Therapeutics (NASDAQ:MAZE)

Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$274.09M
Number of
Institutional Sellers
(last 12 months)
0
Get MAZE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Maze Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MAZE Institutional Buying and Selling by Quarter

Maze Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030%
5/29/2025Rhumbline Advisers7,235$80K0.0%N/A0.017%
5/16/2025Woodline Partners LP929,102$10.23M0.1%N/A2.121%
5/16/2025Octagon Capital Advisors LP468,000$5.15M0.6%N/A1.069%
5/16/2025Goldman Sachs Group Inc.13,129$145K0.0%N/A0.030%
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,135$57K0.0%N/A0.012%
5/16/2025ARCH Venture Management LLC4,120,053$45.36M22.0%N/A9.407%
5/16/2025Alyeska Investment Group L.P.125,000$1.38M0.0%N/A0.285%
5/15/2025Frazier Life Sciences Management L.P.4,129,001$45.46M2.1%N/A9.428%
5/15/2025Hhlr Advisors LTD.457,535$5.04M0.1%N/A1.045%
5/15/2025Ghisallo Capital Management LLC30,000$330K0.0%N/A0.068%
5/15/2025Driehaus Capital Management LLC132,115$1.46M0.0%N/A0.302%
5/14/2025Affinity Asset Advisors LLC250,000$2.75M0.3%N/A0.571%
5/14/2025Corebridge Financial Inc.4,328$48K0.0%N/A0.010%
5/14/2025Matrix Capital Management Company LP2,486,184$27.37M7.9%N/A5.677%
5/12/2025Nuveen LLC11,375$125K0.0%N/A0.026%
5/12/2025Invesco Ltd.20,552$226K0.0%N/A0.047%
5/9/2025Deutsche Bank AG8,885$98K0.0%N/A0.020%
5/9/2025TRV GP V LLC950,800$10.47M8.4%N/A2.171%
5/9/2025TRV GP IV LLC6,073,958$66.87M72.0%N/A13.869%
5/9/2025Charles Schwab Investment Management Inc.72,305$796K0.0%N/A0.165%
5/9/2025Harvard Management Co. Inc.637,528$7.02M0.6%N/A1.456%
5/2/2025Alphabet Inc.2,412,471$26.56M1.7%N/A5.508%
5/1/2025New York State Common Retirement Fund2,300$25K0.0%N/A0.005%
4/29/2025Bank of New York Mellon Corp17,233$190K0.0%N/A0.039%
4/23/2025Bessemer Group Inc.481,790$5.31M0.0%N/A1.100%
4/16/2025General Catalyst Group Management LLC1,035,910$11.41M1.3%N/A2.365%
(Data available from 1/1/2016 forward)

MAZE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MAZE shares?

During the previous two years, 26 institutional investors and hedge funds held shares of Maze Therapeutics. The most heavily invested institutionals were TRV GP IV LLC ($66.87M), Frazier Life Sciences Management L.P. ($45.46M), ARCH Venture Management LLC ($45.36M), Matrix Capital Management Company LP ($27.37M), Alphabet Inc. ($26.56M), General Catalyst Group Management LLC ($11.41M), and TRV GP V LLC ($10.47M).Learn more on Maze Therapeutics' institutional investors.

Which institutional investors have been buying Maze Therapeutics' stock?

Of the 26 institutional investors that purchased Maze Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP IV LLC ($6.07M), Frazier Life Sciences Management L.P. ($4.13M), ARCH Venture Management LLC ($4.12M), Matrix Capital Management Company LP ($2.49M), Alphabet Inc. ($2.41M), General Catalyst Group Management LLC ($1.04M), and TRV GP V LLC ($950.80K).

How much institutional buying is happening at Maze Therapeutics?

Institutional investors have bought a total of 24,895,053 shares in the last 24 months. This purchase volume represents approximately $274.09M in transactions.


Related Companies

This page (NASDAQ:MAZE) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Revolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial Underway
Tiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!
Interactive Offers | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Central Banks Are Hoarding Gold – Should You?
The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...
Lear Capital | Sponsored
Major Rollout of Social Security X?
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...
Golden Portfolio | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored